Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Update in Cystic Fibrosis 2014.

Ong T, Ramsey BW.

Am J Respir Crit Care Med. 2015 Sep 15;192(6):669-75. doi: 10.1164/rccm.201504-0656UP. Review. No abstract available.

PMID:
26371812
2.

Breakthrough therapies: Cystic fibrosis (CF) potentiators and correctors.

Solomon GM, Marshall SG, Ramsey BW, Rowe SM.

Pediatr Pulmonol. 2015 Oct;50 Suppl 40:S3-S13. doi: 10.1002/ppul.23240. Epub 2015 Jun 19. Review.

3.

Clinical mechanism of the cystic fibrosis transmembrane conductance regulator potentiator ivacaftor in G551D-mediated cystic fibrosis.

Rowe SM, Heltshe SL, Gonska T, Donaldson SH, Borowitz D, Gelfond D, Sagel SD, Khan U, Mayer-Hamblett N, Van Dalfsen JM, Joseloff E, Ramsey BW; GOAL Investigators of the Cystic Fibrosis Foundation Therapeutics Development Network.

Am J Respir Crit Care Med. 2014 Jul 15;190(2):175-84. doi: 10.1164/rccm.201404-0703OC.

4.

Modifying disease in cystic fibrosis: current and future therapies on the horizon.

Ong T, Ramsey BW.

Curr Opin Pulm Med. 2013 Nov;19(6):645-51. doi: 10.1097/MCP.0b013e328365ab5f. Review.

PMID:
24048086
5.

Cystic fibrosis therapeutics: the road ahead.

Hoffman LR, Ramsey BW.

Chest. 2013 Jan;143(1):207-213. doi: 10.1378/chest.12-1639. Review.

6.

Progress in cystic fibrosis and the CF Therapeutics Development Network.

Rowe SM, Borowitz DS, Burns JL, Clancy JP, Donaldson SH, Retsch-Bogart G, Sagel SD, Ramsey BW.

Thorax. 2012 Oct;67(10):882-90. doi: 10.1136/thoraxjnl-2012-202550.

7.

Future directions in early cystic fibrosis lung disease research: an NHLBI workshop report.

Ramsey BW, Banks-Schlegel S, Accurso FJ, Boucher RC, Cutting GR, Engelhardt JF, Guggino WB, Karp CL, Knowles MR, Kolls JK, LiPuma JJ, Lynch S, McCray PB Jr, Rubenstein RC, Singh PK, Sorscher E, Welsh M.

Am J Respir Crit Care Med. 2012 Apr 15;185(8):887-92. doi: 10.1164/rccm.201111-2068WS. Epub 2012 Feb 3.

8.

Genome mosaicism is conserved but not unique in Pseudomonas aeruginosa isolates from the airways of young children with cystic fibrosis.

Ernst RK, D'Argenio DA, Ichikawa JK, Bangera MG, Selgrade S, Burns JL, Hiatt P, McCoy K, Brittnacher M, Kas A, Spencer DH, Olson MV, Ramsey BW, Lory S, Miller SI.

Environ Microbiol. 2003 Dec;5(12):1341-9.

PMID:
14641578
9.

Pathophysiology and management of pulmonary infections in cystic fibrosis.

Gibson RL, Burns JL, Ramsey BW.

Am J Respir Crit Care Med. 2003 Oct 15;168(8):918-51. Review.

PMID:
14555458
10.

The cystic fibrosis therapeutics development network (CF TDN): a paradigm of a clinical trials network for genetic and orphan diseases.

Goss CH, Mayer-Hamblett N, Kronmal RA, Ramsey BW.

Adv Drug Deliv Rev. 2002 Dec 5;54(11):1505-28. Review.

PMID:
12458158
11.

A phase I study of aerosolized administration of tgAAVCF to cystic fibrosis subjects with mild lung disease.

Aitken ML, Moss RB, Waltz DA, Dovey ME, Tonelli MR, McNamara SC, Gibson RL, Ramsey BW, Carter BJ, Reynolds TC.

Hum Gene Ther. 2001 Oct 10;12(15):1907-16.

PMID:
11589832
12.

Management of pulmonary disease in patients with cystic fibrosis.

Ramsey BW.

N Engl J Med. 1996 Jul 18;335(3):179-88. Review. No abstract available. Erratum in: N Engl J Med 1996 Oct 10;335(15):1167.

PMID:
8657217
13.

Repeat administration of an adenovirus vector encoding cystic fibrosis transmembrane conductance regulator to the nasal epithelium of patients with cystic fibrosis.

Zabner J, Ramsey BW, Meeker DP, Aitken ML, Balfour RP, Gibson RL, Launspach J, Moscicki RA, Richards SM, Standaert TA, et al.

J Clin Invest. 1996 Mar 15;97(6):1504-11.

14.

Nutritional assessment and management in cystic fibrosis: a consensus report. The Consensus Committee.

Ramsey BW, Farrell PM, Pencharz P.

Am J Clin Nutr. 1992 Jan;55(1):108-16. Review.

PMID:
1728810

Supplemental Content

Loading ...
Support Center